Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial
Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page
- Check6 days agoChange DetectedThe page shows a minor version update from v3.4.1 to v3.4.2 with no changes to study content or visible functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedA new Revision: v3.4.1 is shown and Revision: v3.4.0 is removed, which appears to be an internal version update rather than a change to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no observable changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded a Locations section with California and Pennsylvania sites (Santa Monica/UCLA, Pittsburgh/UPMC) and updated the revision footer to v3.3.3.SummaryDifference0.4%

- Check86 days agoChange DetectedThe page revision changed from v3.2.0 to v3.3.2, and no study content or sections appear to be affected.SummaryDifference0.1%

- Check93 days agoChange DetectedNotice about government funding and operating status was removed from the page; the rest of the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.